{
  "cik": 728387,
  "cik_padded": "0000728387",
  "entityName": "Perspective Therapeutics, Inc.",
  "fiscal_years": [
    {
      "accn": "0000728387-26-000004",
      "filed": "2026-03-16",
      "fiscal_year": 2025,
      "form": "10-K",
      "fundamental_units": {
        "capex": "USD",
        "cash": "USD",
        "eps_diluted": "USD/shares",
        "free_cash_flow": "USD",
        "net_income": "USD",
        "operating_cash_flow": "USD",
        "operating_income": "USD",
        "stockholders_equity": "USD",
        "total_assets": "USD",
        "total_liabilities": "USD"
      },
      "fundamentals": {
        "capex": 12749000.0,
        "cash": 30629000.0,
        "eps_diluted": -1.4,
        "free_cash_flow": -95233000.0,
        "net_income": -103121000.0,
        "operating_cash_flow": -82484000.0,
        "operating_income": -113564000.0,
        "stockholders_equity": 207031000.0,
        "total_assets": 266972000.0,
        "total_liabilities": 59941000.0
      },
      "period_end": "2025-12-31",
      "ratio_units": {
        "leverage": "ratio",
        "roa_avg2y": "ratio",
        "roa_period_end": "ratio",
        "roe_avg2y": "ratio",
        "roe_period_end": "ratio"
      },
      "ratios": {
        "leverage": 0.2895266892397757,
        "roa_avg2y": -0.3391730927043299,
        "roa_period_end": -0.3862614806047076,
        "roe_avg2y": -0.4143910275085946,
        "roe_period_end": -0.49809448826504243
      }
    },
    {
      "accn": "0000728387-26-000004",
      "filed": "2026-03-16",
      "fiscal_year": 2024,
      "form": "10-K",
      "fundamental_units": {
        "capex": "USD",
        "cash": "USD",
        "eps_diluted": "USD/shares",
        "free_cash_flow": "USD",
        "net_income": "USD",
        "operating_cash_flow": "USD",
        "operating_income": "USD",
        "stockholders_equity": "USD",
        "total_assets": "USD",
        "total_liabilities": "USD"
      },
      "fundamentals": {
        "capex": 54414000.0,
        "cash": 61580000.0,
        "eps_diluted": -1.23,
        "free_cash_flow": -72708000.0,
        "net_income": -79279000.0,
        "operating_cash_flow": -18294000.0,
        "operating_income": -90886000.0,
        "stockholders_equity": 290668000.0,
        "total_assets": 341101000.0,
        "total_liabilities": 50433000.0
      },
      "period_end": "2024-12-31",
      "ratio_units": {
        "leverage": "ratio",
        "roa_avg2y": "ratio",
        "roa_period_end": "ratio",
        "roe_avg2y": "ratio",
        "roe_period_end": "ratio"
      },
      "ratios": {
        "leverage": 0.17350723161820358,
        "roa_avg2y": -0.36118653642890985,
        "roa_period_end": -0.2324208958636885,
        "roe_avg2y": -0.4333997545421993,
        "roe_period_end": -0.27274760207521986
      }
    },
    {
      "accn": "0000950170-25-046758",
      "filed": "2026-03-16",
      "fiscal_year": 2023,
      "form": "10-K",
      "fundamental_units": {
        "capex": "USD",
        "cash": "USD",
        "eps_diluted": "USD/shares",
        "free_cash_flow": "USD",
        "net_income": "USD",
        "operating_cash_flow": "USD",
        "operating_income": "USD",
        "stockholders_equity": "USD",
        "total_assets": "USD",
        "total_liabilities": "USD"
      },
      "fundamentals": {
        "capex": 1072000.0,
        "cash": 9238000.0,
        "eps_diluted": -1.74,
        "free_cash_flow": -37985000.0,
        "net_income": -46508000.0,
        "operating_cash_flow": -36913000.0,
        "operating_income": -40941000.0,
        "stockholders_equity": 75179000.0,
        "total_assets": 97891000.0,
        "total_liabilities": 22712000.0
      },
      "period_end": "2023-12-31",
      "ratio_units": {
        "leverage": "ratio",
        "roa_avg2y": "ratio",
        "roa_period_end": "ratio",
        "roe_avg2y": "ratio",
        "roe_period_end": "ratio"
      },
      "ratios": {
        "leverage": 0.3021056412029955,
        "roa_avg2y": -0.5963252170122194,
        "roa_period_end": -0.47509985596224374,
        "roe_avg2y": -0.7164942497746898,
        "roe_period_end": -0.6186302025831681
      }
    },
    {
      "accn": "0001437749-24-009696",
      "filed": "2025-03-28",
      "fiscal_year": 2022,
      "form": "10-K",
      "fundamental_units": {
        "capex": "USD",
        "cash": "USD",
        "free_cash_flow": "USD",
        "net_income": "USD",
        "operating_cash_flow": "USD",
        "operating_income": "USD",
        "stockholders_equity": "USD",
        "total_assets": "USD",
        "total_liabilities": "USD"
      },
      "fundamentals": {
        "capex": 282000.0,
        "cash": 20993000.0,
        "free_cash_flow": -10683000.0,
        "net_income": -10760000.0,
        "operating_cash_flow": -10401000.0,
        "operating_income": -8672000.0,
        "stockholders_equity": 54642000.0,
        "total_assets": 58091000.0,
        "total_liabilities": 3449000.0
      },
      "period_end": "2022-12-31",
      "ratio_units": {
        "leverage": "ratio",
        "roa_avg2y": "ratio",
        "roa_period_end": "ratio",
        "roe_avg2y": "ratio",
        "roe_period_end": "ratio"
      },
      "ratios": {
        "leverage": 0.06311994436514037,
        "roa_avg2y": -0.16746169469367428,
        "roa_period_end": -0.18522662718837682,
        "roe_avg2y": -0.17632406921866806,
        "roe_period_end": -0.1969181215914498
      }
    },
    {
      "accn": "0001437749-24-009696",
      "filed": "2024-03-28",
      "fiscal_year": 2021,
      "form": "10-K",
      "fundamental_units": {
        "capex": "USD",
        "cash": "USD",
        "free_cash_flow": "USD",
        "net_income": "USD",
        "operating_cash_flow": "USD",
        "operating_income": "USD",
        "stockholders_equity": "USD",
        "total_assets": "USD",
        "total_liabilities": "USD"
      },
      "fundamentals": {
        "capex": 381000.0,
        "cash": 63828000.0,
        "free_cash_flow": -3218000.0,
        "net_income": -3387000.0,
        "operating_cash_flow": -2837000.0,
        "operating_income": -3446000.0,
        "stockholders_equity": 67406000.0,
        "total_assets": 70416000.0,
        "total_liabilities": 3010000.0
      },
      "period_end": "2021-06-30",
      "ratio_units": {
        "leverage": "ratio",
        "roa_avg2y": "ratio",
        "roa_period_end": "ratio",
        "roe_avg2y": "ratio",
        "roe_period_end": "ratio"
      },
      "ratios": {
        "leverage": 0.04465477850636442,
        "roa_avg2y": -0.08562219553814068,
        "roa_period_end": -0.04809986366734833,
        "roe_avg2y": -0.09263083045030016,
        "roe_period_end": -0.050247752425600097
      }
    },
    {
      "accn": "0001437749-22-023188",
      "filed": "2022-09-28",
      "fiscal_year": 2020,
      "form": "10-K",
      "fundamental_units": {
        "capex": "USD",
        "cash": "USD",
        "free_cash_flow": "USD",
        "net_income": "USD",
        "operating_cash_flow": "USD",
        "operating_income": "USD",
        "stockholders_equity": "USD",
        "total_assets": "USD",
        "total_liabilities": "USD"
      },
      "fundamentals": {
        "capex": 273000.0,
        "cash": 2392000.0,
        "free_cash_flow": -3914000.0,
        "net_income": -3446000.0,
        "operating_cash_flow": -3641000.0,
        "operating_income": -3476000.0,
        "stockholders_equity": 5723000.0,
        "total_assets": 8699000.0,
        "total_liabilities": 2976000.0
      },
      "period_end": "2020-06-30",
      "ratio_units": {
        "leverage": "ratio",
        "roa_avg2y": "ratio",
        "roa_period_end": "ratio",
        "roe_avg2y": "ratio",
        "roe_period_end": "ratio"
      },
      "ratios": {
        "leverage": 0.5200069893412546,
        "roa_avg2y": -0.3803322112466199,
        "roa_period_end": -0.39613748706747903,
        "roe_avg2y": -0.5142132358427218,
        "roe_period_end": -0.602131749082649
      }
    },
    {
      "accn": "0001437749-22-023188",
      "filed": "2022-09-28",
      "fiscal_year": 2019,
      "form": "10-K",
      "fundamental_units": {
        "capex": "USD",
        "cash": "USD",
        "free_cash_flow": "USD",
        "net_income": "USD",
        "operating_cash_flow": "USD",
        "operating_income": "USD",
        "stockholders_equity": "USD",
        "total_assets": "USD",
        "total_liabilities": "USD"
      },
      "fundamentals": {
        "capex": 444000.0,
        "cash": 5326000.0,
        "free_cash_flow": -5493000.0,
        "net_income": -5144000.0,
        "operating_cash_flow": -5049000.0,
        "operating_income": -5254000.0,
        "stockholders_equity": 7680000.0,
        "total_assets": 9422000.0,
        "total_liabilities": 1742000.0
      },
      "period_end": "2019-06-30",
      "ratio_units": {
        "leverage": "ratio",
        "roa_avg2y": "ratio",
        "roa_period_end": "ratio",
        "roe_avg2y": "ratio",
        "roe_period_end": "ratio"
      },
      "ratios": {
        "leverage": 0.22682291666666668,
        "roa_avg2y": -0.6095870119096995,
        "roa_period_end": -0.5459562725535979,
        "roe_avg2y": -0.809441384736428,
        "roe_period_end": -0.6697916666666667
      }
    },
    {
      "accn": "0001437749-21-022693",
      "filed": "2021-09-27",
      "fiscal_year": 2018,
      "form": "10-K",
      "fundamental_units": {
        "capex": "USD",
        "cash": "USD",
        "free_cash_flow": "USD",
        "net_income": "USD",
        "operating_cash_flow": "USD",
        "operating_income": "USD",
        "stockholders_equity": "USD",
        "total_assets": "USD",
        "total_liabilities": "USD"
      },
      "fundamentals": {
        "capex": 337000.0,
        "cash": 2600000.0,
        "free_cash_flow": -6049000.0,
        "net_income": -6700000.0,
        "operating_cash_flow": -5712000.0,
        "operating_income": -6729000.0,
        "stockholders_equity": 5030000.0,
        "total_assets": 7455000.0,
        "total_liabilities": 2425000.0
      },
      "period_end": "2018-06-30",
      "ratio_units": {
        "leverage": "ratio",
        "roa_avg2y": "ratio",
        "roa_period_end": "ratio",
        "roe_avg2y": "ratio",
        "roe_period_end": "ratio"
      },
      "ratios": {
        "leverage": 0.4821073558648111,
        "roa_avg2y": -0.6793753802474143,
        "roa_period_end": -0.8987256874580818,
        "roe_avg2y": -0.8572159672466735,
        "roe_period_end": -1.332007952286282
      }
    },
    {
      "accn": "0001437749-20-020189",
      "filed": "2020-09-25",
      "fiscal_year": 2017,
      "form": "10-K",
      "fundamental_units": {
        "capex": "USD",
        "cash": "USD",
        "free_cash_flow": "USD",
        "net_income": "USD",
        "operating_cash_flow": "USD",
        "operating_income": "USD",
        "stockholders_equity": "USD",
        "total_assets": "USD",
        "total_liabilities": "USD"
      },
      "fundamentals": {
        "capex": 549000.0,
        "cash": 5932000.0,
        "free_cash_flow": -6261000.0,
        "net_income": -6162000.0,
        "operating_cash_flow": -5712000.0,
        "operating_income": -6307000.0,
        "stockholders_equity": 10602000.0,
        "total_assets": 12269000.0,
        "total_liabilities": 1667000.0
      },
      "period_end": "2017-06-30",
      "ratio_units": {
        "leverage": "ratio",
        "roa_avg2y": "ratio",
        "roa_period_end": "ratio",
        "roe_avg2y": "ratio",
        "roe_period_end": "ratio"
      },
      "ratios": {
        "leverage": 0.1572344840596114,
        "roa_avg2y": -0.40578183135227686,
        "roa_period_end": -0.5022414214687424,
        "roe_avg2y": -0.45639373402955224,
        "roe_period_end": -0.5812110922467459
      }
    },
    {
      "accn": "0001437749-19-019176",
      "filed": "2019-09-27",
      "fiscal_year": 2016,
      "form": "10-K",
      "fundamental_units": {
        "capex": "USD",
        "cash": "USD",
        "free_cash_flow": "USD",
        "net_income": "USD",
        "operating_cash_flow": "USD",
        "operating_income": "USD",
        "stockholders_equity": "USD",
        "total_assets": "USD",
        "total_liabilities": "USD"
      },
      "fundamentals": {
        "capex": 479000.0,
        "cash": 10139000.0,
        "free_cash_flow": -4363000.0,
        "net_income": -4711000.0,
        "operating_cash_flow": -3884000.0,
        "operating_income": -5082000.0,
        "stockholders_equity": 16401000.0,
        "total_assets": 18102000.0,
        "total_liabilities": 1701000.0
      },
      "period_end": "2016-06-30",
      "ratio_units": {
        "leverage": "ratio",
        "roa_period_end": "ratio",
        "roe_period_end": "ratio"
      },
      "ratios": {
        "leverage": 0.10371318822023047,
        "roa_period_end": -0.26024748646558393,
        "roe_period_end": -0.2872385830132309
      }
    }
  ],
  "latest_filing": {
    "accn": "0000728387-26-000004",
    "filed": "2026-03-16",
    "form": "10-K"
  },
  "note": "Static grepcent export of verified SEC companyfacts-derived values. Monetary values are raw reported units from grepcent's resolved facts; no scaling and no FX conversion. Capex, dividends, and buybacks are reported as positive outflow magnitudes. ROE/ROA include both period-end basis (site-consistent) and average-of-two-years basis where the prior-year denominator exists.",
  "schema_version": "1",
  "sic": "2834",
  "sic_description": "Pharmaceutical Preparations",
  "source_urls": {
    "sec_companyfacts": "https://data.sec.gov/api/xbrl/companyfacts/CIK0000728387.json",
    "sec_submissions": "https://data.sec.gov/submissions/CIK0000728387.json"
  },
  "ticker": "CATX"
}
